CEO Martin Lehr outlined the company’s strategy and upcoming clinical milestones at the 46th Annual TD Cowen Healthcare Conference, positioning the biotechnology company as a developer of T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results